Exploring Available Plastic Surgery Reward Programs and Proposing a Modeled Approach.

There is a paucity of literature exploring private practice reward programs within plastic and aesthetic surgery. In this study, the authors explore private practice websites and identify universal commercial programs and practice-specific programs being adopted. They aim to evaluate the current landscape of private practice reward programs by examining their advantages and limitations. Additionally, they propose an "ideal" loyalty program that could enhance patient engagement, satisfaction, and practice growth. A review was performed to identify available reward programs and models. Private practice websites were examined for available reward models. Commercial loyalty programs were cross-referenced to determine practices leveraging them. Data collected included private practice reward program type, region, and total surgeons at the practice. Advantages and areas of improvement were analyzed of existing programs and discussions with private practice surgeons generated proposals of an ideal loyalty program model. There were no articles on plastic surgery reward programs. Private practice websites suggested 3 universal reward systems, including Allē (Allergan, Inc., Dublin, Ireland), Aspire (Galderma, Lausanne, Switzerland), and Evolus (Newport Beach, CA). A total of 4 private practices with custom reward programs were identified. Universal reward systems are point-based and often lack excitement for the consumer. These benefits accumulate points across different providers, but often lack practice-specific reward opportunities. Although beneficial, most commercially available loyalty programs do not integrate into electronic medical records (EMRs) to track usage and challenges exist in tracking patient utilization. The ideal platform harmonizes the advantages of commercial loyalty programs with tailored practice-specific rewards while having the capacity to integrate with the EMR and capture patient utilization. Level of Evidence 5 Therapeutic: